Infinity Pharmaceuticals reported $45K in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbvie ABBV:US $ 548M 32M
Amgen AMGN:US $ 295M 40M
Bristol Myers Squibb BMY:US $ 326M 3M
Cytori Therapeutics CYTX:US $ 198K 26K
Eli Lilly And LLY:US $ 84.9M 3.5M
Gilead Sciences GILD:US $ 238M 0M
Infinity Pharmaceuticals INFI:US $ 0.04M 0M
Johnson & Johnson JNJ:US $ 10M 50M
Novartis NOVN:VX 201M 5M
Pfizer PFE:US $ 322M 6M
Tg Therapeutics TGTX:US $ 2.66M 1.58M
Vascular Biogenics VBLT:US 10K 1000
YTE INCY:US $ 0.68M 0.07M